tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market
CRSP
Crispr Therapeutics AG
RESEARCH TOOLSreports

Crispr Therapeutics AG (CRSP) Income Statement

10,881 Followers

Crispr Therapeutics AG Income Statement

Last quarter (Q4 2025), Crispr Therapeutics AG's total revenue was $864.00K, a decrease of -97.53% from the same quarter last year. In Q4, Crispr Therapeutics AG's net income was $-130.61M. See Crispr Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.51M$ 35.00M$ 370.00M$ 436.00K$ 913.08M
Gross Profit
$ -229.45M$ -75.25M$ 239.75M$ -109.81M$ 811.90M
Operating Expenses
$ 338.87M$ 391.32M$ 462.29M$ 563.35M$ 438.38M
Depreciation and Amortization
$ 19.48M$ 19.26M$ 19.84M$ 24.17M$ 17.95M
EBITDA
$ -548.84M$ -447.31M$ -202.70M$ -648.99M$ 391.48M
Operating Income
$ -568.32M$ -466.57M$ -222.54M$ -673.16M$ 373.53M
Other Income/Expenses
$ -9.65M$ 103.90M$ 71.82M$ 22.66M$ 6.00M
Pretax Income
$ -577.97M$ -362.67M$ -150.72M$ -650.50M$ 379.53M
Net Income
$ -581.60M$ -366.25M$ -153.61M$ -650.17M$ 377.66M
Per Share Metrics
Basic EPS
$ -6.47$ -4.34$ -1.94$ -8.36$ 4.97
Diluted EPS
$ -6.47$ -4.34$ -1.94$ -8.36$ 4.70
Weighted Average Shares Outstanding
 89.93M 84.36M 79.22M 77.75M 75.95M
Weighted Average Shares Outstanding (Diluted)
 89.93M 84.36M 79.22M 77.75M 80.39M
Currency in USD

Crispr Therapeutics AG Earnings and Revenue History